secwatch.observer — SEC 8-K summary
======================================

Issuer:     Serina Therapeutics, Inc. (SER)
CIK:        0001708599
Form:       8-K
Filed at:   2024-09-12T23:59:59+00:00
Accession:  0001493152-24-036080
Event type: leadership
Sentiment:  neutral
Materiality: 0.65
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Serina Therapeutics appoints Steven Ledger as permanent CEO; base $450k, options grant
--------------------------------------------------------------------------------

- Steven Ledger, interim CEO since March 2024, appointed permanent CEO effective Sept 8, 2024.
- Annual base salary $450,000, increasing to $500,000 upon strategic goal; bonus up to 50% of base.
- Received 501,851 stock options; 75% time-vested over 4 years, 25% performance-based.
- Severance: 12 months base plus prorated bonus (min half) if terminated without cause.
- Ledger has 35+ years experience; retains board seat.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1708599/000149315224036080/0001493152-24-036080-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1708599/000149315224036080/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-036080

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer